Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials

To assess the association of the vitreomacular interface with outcomes of eyes treated with anti-vascular endothelial growth factor drugs for neovascular age-related macular degeneration (AMD). Prospective cohort study within a multicenter, randomized clinical trial. Patients enrolled in the Compari...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Ophthalmology (Rochester, Minn.) Ročník 122; číslo 6; s. 1203
Hlavní autori:	Ciulla, Thomas A, Cuilla, Thomas A, Ying, Gui-Shuang, Maguire, Maureen G, Martin, Daniel F, Jaffe, Glenn J, Grunwald, Juan E, Daniel, Ebenezer, Toth, Cynthia A
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.06.2015
Predmet:	Aged Aged, 80 and over Angiogenesis Inhibitors - administration & dosage Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - therapeutic use Bevacizumab Blood-Retinal Barrier Cohort Studies Female Fluorescein Angiography Humans Intravitreal Injections Macula Lutea - pathology Male Prospective Studies Ranibizumab Retinal Diseases - complications Subretinal Fluid Tissue Adhesions Tomography, Optical Coherence Treatment Outcome Vascular Endothelial Growth Factor A - antagonists & inhibitors Visual Acuity - physiology Vitreous Body - pathology Wet Macular Degeneration - diagnosis Wet Macular Degeneration - drug therapy Wet Macular Degeneration - physiopathology
ISSN:	1549-4713, 1549-4713
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!